After a stroke, people often lose dexterity in one hand. Now, the Food and Drug Administration has authorized a device that can restore function by encouraging the brain to rewire.

More than two dozen states have reduced how frequently they report what's happening with the pandemic, raising alarm among some public health experts.

Cities are leaving rural areas behind in the race to vaccinate against COVID-19, but some states' suburbs are struggling, too. To close the gap experts say, outreach needs to be hyperlocal.

An analysis of blood from people who had received the Johnson & Johnson COVID-19 vaccine found a lower level of neutralizing antibodies against viral variants but a strong response involving T cells.

Instead of putting genetic instructions into people whose cells then make a viral protein, the vaccines from Novavax, Medicago and Sanofi carry a spike protein payload.

The FDA has until Monday to decide whether to approve the first new Alzheimer's drug in nearly two decades. Two big studies of the drug produced conflicting results.

Despite a massive hiring push last year, health agencies around the U.S. failed to contain the pandemic through contact tracing. Health leaders reflect on lessons learned and what's next.

Hundreds of people got HIV from sharing dirty needles in rural Scott County, Ind. On Wednesday, county commissioners voted to shutter the syringe exchange widely credited with containing the outbreak.

Until recently, plants from only one U.S. facility were approved for use in research. Adding new suppliers will accelerate understanding of cannabis' health effects and possible therapeutic uses.

Many Asian Americans live daily with the corrosive effects of racism and racialized violence, yet there's very little research funded on Asian American health.